Paradoxical Reduction in HDL-C With Fenofibrate and Thiazolidinedione Therapy in Type 2 Diabetes: The ACCORD Lipid Trial

✍ Scribed by Linz, P. E.; Lovato, L. C.; Byington, R. P.; O'Connor, P. J.; Leiter, L. A.; Weiss, D.; Force, R. W.; Crouse, J. R.; Ismail-Beigi, F.; Simmons, D. L.; Papademetriou, V.; Ginsberg, H. N.; Elam, M. B.

• Book ID: 125501072
• Publisher: American Diabetes Association
• Year: 2013
• Tongue: English
• Weight: 819 KB
• Volume: 37
• Category: Article
• ISSN: 0149-5992
• DOI: 10.2337/dc13-0790